Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.
Hepprich M, Mudry JM, Gregoriano C, Jornayvaz FR, Carballo S, Wojtusciszyn A, Bart PA, Chiche JD, Fischli S, Baumgartner T, Cavelti-Weder C, Braun DL, Günthard HF, Beuschlein F, Conen A, West E, Isenring E, Zechmann S, Bucklar G, Aubry Y, Dey L, Müller B, Hunziker P, Schütz P, Cattaneo M, Donath MY. Hepprich M, et al. Among authors: donath my. EClinicalMedicine. 2022 Sep 17;53:101649. doi: 10.1016/j.eclinm.2022.101649. eCollection 2022 Nov. EClinicalMedicine. 2022. PMID: 36128334 Free PMC article.
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H, Solinger AM, Mandrup-Poulsen T, Dinarello CA, Donath MY. Cavelti-Weder C, et al. Among authors: donath my. Diabetes Care. 2012 Aug;35(8):1654-62. doi: 10.2337/dc11-2219. Epub 2012 Jun 14. Diabetes Care. 2012. PMID: 22699287 Free PMC article. Clinical Trial.
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.
Cavelti-Weder C, Timper K, Seelig E, Keller C, Osranek M, Lässing U, Spohn G, Maurer P, Müller P, Jennings GT, Willers J, Saudan P, Donath MY, Bachmann MF. Cavelti-Weder C, et al. Among authors: donath my. Mol Ther. 2016 May;24(5):1003-12. doi: 10.1038/mt.2015.227. Epub 2015 Dec 21. Mol Ther. 2016. PMID: 26686385 Free PMC article. Clinical Trial.
The role of IL-1 in postprandial fatigue.
Lehrskov LL, Dorph E, Widmer AM, Hepprich M, Siegenthaler J, Timper K, Donath MY. Lehrskov LL, et al. Among authors: donath my. Mol Metab. 2018 Jun;12:107-112. doi: 10.1016/j.molmet.2018.04.001. Epub 2018 Apr 12. Mol Metab. 2018. PMID: 29705519 Free PMC article. Clinical Trial.
Treatment of Primary Aldosteronism With mTORC1 Inhibitors.
Trinh B, Hepprich M, Betz MJ, Burkard T, Cavelti-Weder C, Seelig E, Meienberg F, Kratschmar DV, Beuschlein F, Reincke M, Odermatt A, Hall MN, Donath MY, Swierczynska MM. Trinh B, et al. Among authors: donath my. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4703-4714. doi: 10.1210/jc.2019-00563. J Clin Endocrinol Metab. 2019. PMID: 31087053 Clinical Trial.
Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study.
Hepprich M, Zillig D, Florian-Reynoso MA, Donath MY, Rudofsky G. Hepprich M, et al. Among authors: donath my. Diabetes Ther. 2021 Mar;12(3):943-954. doi: 10.1007/s13300-021-01016-y. Epub 2021 Feb 22. Diabetes Ther. 2021. PMID: 33615400 Free PMC article.
186 results